News

Fierce Pharma31m
Novo moves past GLP-1 spat with Hims & Hers, tapping telehealth company to offer discounted Wegovy
Novo Nordisk appears to be letting compounded GLP-1 bygones be bygones—at least, in one respect. | Novo Nordisk appears to be ...
Fierce Pharma43m
As Novartis builds momentum with new drug launches, CEO says he's 'comfortable' navigating US tariffs
Novartis has a lot cooking with new drug launches, and the company is not letting potential U.S. tariffs on pharmaceuticals ...